Related Experiment Videos
Randomized clinical trials in single patients during a 2-year period
E B Larson1, A J Ellsworth, J Oas
1Department of Medicine, School of Medicine, University of Washington, Seattle.
JAMA
|December 8, 1993
Summary
Single patient trials (SPTs) are feasible and cost-effective, providing valuable data to guide treatment decisions for chronic diseases. These formal SPTs enhance therapeutic precision and clinician confidence.
Area of Science:
- Clinical research methodology
- Pharmacoeconomics
- Evidence-based medicine
Background:
- Single patient trials (SPTs) offer a personalized approach to treatment evaluation.
- Assessing the feasibility and impact of a formal SPT service is crucial for optimizing patient care.
Purpose of the Study:
- To evaluate the feasibility of implementing a single patient trial (SPT) service.
- To determine the influence of formal SPTs on therapeutic precision and clinical decision-making.
Main Methods:
- A descriptive and evaluative study of SPTs conducted over two years (1988-1990).
- Trials were double-blind, randomized, multiple crossover designs with random assignment and explicit outcome assessment.
- Patient and physician confidence levels were measured using visual analog scales pre- and post-trial.
Main Results:
- Of 34 completed SPTs, 17 yielded definitive results. Treatment was continued or initiated in 16 trials based on positive outcomes.
- Treatment was discontinued or not initiated in 18 trials due to ineffectiveness, harm, or equivalence.
- Physicians' confidence increased or decreased based on trial outcomes, while most patients reported no change; the service was rated highly useful.
Conclusions:
- A single patient trial (SPT) service is feasible, with costs comparable to conventional services.
- SPTs enhance clinician confidence and therapeutic precision, particularly for uncertain treatment values in chronic diseases.
- Formal SPTs can effectively guide subsequent treatment decisions when uncertainty exists regarding treatment efficacy or safety.